Production (Stage)
Astrana Health, Inc.
ASTH
$24.29
-$0.18-0.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.01M | 43.15M | 62.46M | 68.42M | 62.42M |
| Total Depreciation and Amortization | 29.68M | 27.93M | 24.70M | 21.74M | 18.55M |
| Total Amortization of Deferred Charges | 2.06M | 1.83M | 1.72M | 1.50M | 1.28M |
| Total Other Non-Cash Items | 44.57M | 42.91M | 11.04M | 18.76M | 11.83M |
| Change in Net Operating Assets | -48.47M | -63.61M | -17.48M | -46.56M | -27.60M |
| Cash from Operations | 62.85M | 52.20M | 82.45M | 63.87M | 66.48M |
| Capital Expenditure | -10.73M | -8.03M | -12.56M | -14.37M | -14.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -95.61M | -146.26M | -117.33M | -121.45M | -57.16M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.41M | -38.10M | -40.61M | -61.45M | -51.32M |
| Cash from Investing | -123.75M | -192.40M | -170.50M | -197.27M | -122.53M |
| Total Debt Issued | 473.88M | 171.88M | 453.25M | 453.11M | 392.91M |
| Total Debt Repaid | -452.41M | -27.71M | -219.67M | -216.10M | -208.73M |
| Issuance of Common Stock | 1.33M | 1.03M | 775.00K | 272.00K | 272.00K |
| Repurchase of Common Stock | -9.65M | -5.60M | -5.20M | -4.24M | -653.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.46M | -95.00K | -59.90M | -62.17M | -62.17M |
| Other Financing Activities | -23.06M | -4.44M | -6.95M | -5.89M | -4.86M |
| Cash from Financing | -15.38M | 135.15M | 162.41M | 165.09M | 116.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.28M | -5.05M | 74.35M | 31.69M | 60.83M |